Tag: Pharmaceuticals
-
The U.S. tariff landscape has shifted again fast, decisively, and with direct consequences for every importer operating into the United States. Following the Supreme Court’s rejection of the Administration’s IEEPA based “reciprocal tariff” program, the White House has executed a rapid pivot to a different legal authority: Section 122 of the Trade Act of 1974,…
-
On November 13, 2025, President Donald J. Trump enacted a consequential amendment to Executive Order 14257, refining the scope of the reciprocal tariffs first introduced in April of the same year. This latest move exempts a carefully selected list of agricultural and input products from tariff obligations, signaling a strategic recalibration of U.S. trade enforcement.…
-
Shared Vision and Strategic Alignment President Donald J. Trump and President Daniel Noboa have affirmed a shared vision for bilateral growth rooted in democratic values, private enterprise, and a rules-based commercial environment. The newly announced Framework for an Agreement on Reciprocal Trade between the United States and Ecuador builds on decades of economic engagement most…
-
The newly announced Framework for an Agreement on Reciprocal Trade between the United States and Guatemala marks a targeted evolution of the CAFTA-DR architecture. Building on nearly two decades of bilateral engagement, this Agreement introduces a modernized compliance ecosystem focused on regulatory streamlining, digital trade facilitation, and economic security alignment. For U.S. stakeholders particularly SMEs…
-
Executive Summary The November 2025 joint statement between President Donald J. Trump and President Javier Milei marks a decisive recalibration of hemispheric trade relations. The Framework for an Agreement on Reciprocal Trade and Investment (the “Agreement”) outlines a bilateral commitment to tariff liberalization, regulatory alignment, and economic security cooperation. For U.S. stakeholders particularly SMEs operating…
-
Belgium and Brazil Sign Generics-Focused Pharma Export Deal: A Strategic Win for Trade, Access, and Innovation In a landmark move that blends trade diplomacy with public health strategy, Belgium has signed a pharmaceutical export agreement with Brazil, targeting the generics sector a domain increasingly recognized as the backbone of affordable healthcare worldwide. The deal was…
-
Updated: December 8th, 2025 The US-UK Pharma Deal: A New Chapter for Trans-Atlantic Pharmaceutical Trade In early December 2025, after months of tense negotiations, the United States and the United Kingdom announced a landmark agreement that could reshape how medicines are traded, priced, and developed on both sides of the Atlantic. The deal promises zero…
-
Trump’s 100% Pharma Tariff + New Duties on Furniture & Trucks: What Importers Must Know Before Oct 1
In a late-night series of posts on September 25, 2025, President Donald Trump unveiled a sweeping set of new tariffs that extend far beyond the traditional battlegrounds of steel and aluminum. The announcements targeted kitchen cabinets, upholstered furniture, heavy trucks, and most dramatically branded pharmaceuticals. The measures, set to take effect October 1, mark one…
-
Author: Maria Pechurina, MA, Director of International Trade @ Peacock Tariff Consulting Earlier in 2025, on St. Patrick’s Day, US President Donald J. Trump lamented that Ireland, a “beautiful island of just 5 million people, has got the entire US pharmaceutical industry in its grasp.” In America’s pursuit of self-sufficiency, its overwhelming reliance on foreign…
-
The U.S.–EU trade deal locks in a uniform 15% tariff on all EU-origin goods entering the United States and eliminates duties on every American export bound for the 27-nation bloc. In return, the EU commits to purchasing $750 billion in U.S. energy products, investing $600 billion across U.S. infrastructure and technology projects, and streamlining defense…